Elliptic Laboratories AS (ELABS) - Net Assets
Based on the latest financial reports, Elliptic Laboratories AS (ELABS) has net assets worth Nkr221.13 Million NOK (≈ $23.27 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr254.49 Million ≈ $26.78 Million USD) and total liabilities (Nkr33.36 Million ≈ $3.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Elliptic Laboratories AS's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr221.13 Million |
| % of Total Assets | 86.89% |
| Annual Growth Rate | 12.91% |
| 5-Year Change | -44.63% |
| 10-Year Change | N/A |
| Growth Volatility | 58.57 |
Elliptic Laboratories AS - Net Assets Trend (2017–2025)
This chart illustrates how Elliptic Laboratories AS's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Elliptic Laboratories AS to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Elliptic Laboratories AS (2017–2025)
The table below shows the annual net assets of Elliptic Laboratories AS from 2017 to 2025. For live valuation and market cap data, see market value of Elliptic Laboratories AS.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr189.79 Million ≈ $19.97 Million |
-41.66% |
| 2024-12-31 | Nkr325.34 Million ≈ $34.24 Million |
+6.53% |
| 2023-12-31 | Nkr305.40 Million ≈ $32.14 Million |
-6.21% |
| 2022-12-31 | Nkr325.62 Million ≈ $34.26 Million |
-5.00% |
| 2021-12-31 | Nkr342.77 Million ≈ $36.07 Million |
+82.22% |
| 2020-12-31 | Nkr188.10 Million ≈ $19.79 Million |
+135.03% |
| 2019-12-31 | Nkr80.03 Million ≈ $8.42 Million |
+68.85% |
| 2018-12-31 | Nkr47.40 Million ≈ $4.99 Million |
-34.04% |
| 2017-12-31 | Nkr71.86 Million ≈ $7.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Elliptic Laboratories AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Nkr1.05 Million | 0.55% |
| Other Components | Nkr188.74 Million | 99.45% |
| Total Equity | Nkr189.79 Million | 100.00% |
Elliptic Laboratories AS Competitors by Market Cap
The table below lists competitors of Elliptic Laboratories AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arribatec Solutions ASA
OL:ARR
|
$38.83 Million |
|
Singtex Industrial Co Ltd
TWO:4433
|
$38.85 Million |
|
Korea Refract
KO:010040
|
$38.86 Million |
|
Microequities Asset Management Group Ltd
AU:MAM
|
$38.88 Million |
|
KCI Limited
KQ:036670
|
$38.80 Million |
|
Bluecom Co. Ltd
KQ:033560
|
$38.79 Million |
|
PT Indo Boga Sukses Tbk
JK:IBOS
|
$38.76 Million |
|
Webstep ASA
OL:WSTEP
|
$38.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elliptic Laboratories AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 325,341,000 to 189,792,000, a change of -135,549,000 (-41.7%).
- Net loss of 138,165,000 reduced equity.
- Share repurchases of 123,000 reduced equity.
- New share issuances of 4,835,000 increased equity.
- Other comprehensive income increased equity by 35,544,000.
- Other factors decreased equity by 37,640,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-138.16 Million | -72.8% |
| Share Repurchases | Nkr123.00K | -0.06% |
| Share Issuances | Nkr4.83 Million | +2.55% |
| Other Comprehensive Income | Nkr35.54 Million | +18.73% |
| Other Changes | Nkr-37.64 Million | -19.83% |
| Total Change | Nkr- | -41.66% |
Book Value vs Market Value Analysis
This analysis compares Elliptic Laboratories AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.62x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.89x to 1.62x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Nkr0.75 | Nkr2.92 | x |
| 2018-12-31 | Nkr0.49 | Nkr2.92 | x |
| 2019-12-31 | Nkr0.79 | Nkr2.92 | x |
| 2020-12-31 | Nkr2.11 | Nkr2.92 | x |
| 2021-12-31 | Nkr3.49 | Nkr2.92 | x |
| 2022-12-31 | Nkr3.13 | Nkr2.92 | x |
| 2023-12-31 | Nkr2.93 | Nkr2.92 | x |
| 2024-12-31 | Nkr2.85 | Nkr2.92 | x |
| 2025-12-31 | Nkr1.80 | Nkr2.92 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Elliptic Laboratories AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -72.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -136.38%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.17x
- Recent ROE (-72.80%) is below the historical average (-25.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -47.66% | -320.24% | 0.11x | 1.37x | Nkr-41.43 Million |
| 2018 | -59.33% | -67.63% | 0.41x | 2.16x | Nkr-32.86 Million |
| 2019 | -16.56% | -34.93% | 0.27x | 1.74x | Nkr-21.26 Million |
| 2020 | -6.65% | -41.40% | 0.14x | 1.16x | Nkr-31.32 Million |
| 2021 | -3.27% | -20.54% | 0.15x | 1.08x | Nkr-45.49 Million |
| 2022 | -10.13% | -63.38% | 0.15x | 1.07x | Nkr-65.56 Million |
| 2023 | -12.44% | -55.62% | 0.20x | 1.14x | Nkr-68.54 Million |
| 2024 | 2.75% | 6.79% | 0.37x | 1.11x | Nkr-23.57 Million |
| 2025 | -72.80% | -136.38% | 0.46x | 1.17x | Nkr-157.14 Million |
Industry Comparison
This section compares Elliptic Laboratories AS's net assets metrics with peer companies in the Software - Infrastructure industry.
Industry Context
- Industry: Software - Infrastructure
- Average net assets among peers: $30,014,450
- Average return on equity (ROE) among peers: -85.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Elliptic Laboratories AS (ELABS) | Nkr221.13 Million | -47.66% | 0.15x | $38.82 Million |
| Lokotech Group AS (LOKO) | $30.01 Million | -85.33% | 0.76x | $42.96 Million |
About Elliptic Laboratories AS
Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on… Read more